Results 61 to 70 of about 9,079 (152)

Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan

open access: yesJournal of Pharmaceutical Policy and Practice, 2017
Background Pharmacists in Japan currently play a key role in patient hospital care. Their responsibilities include filling prescriptions, checking a patient’s medication history, and providing appropriate information to other health care workers.
Daiki Yasunaga   +5 more
doaj   +1 more source

The use of micafungin in neonates and children: A systematic review

open access: yesEuropean Journal of Volunteering and Community-Based Projects, 2020
BACKGROUNG: About 10% of newborns under 1000 g have problems related to candidiasis. The mortality rate is still very high today, and new types of drugs are used for the treatment.
Silvana Secinaro   +4 more
doaj  

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications

open access: yesFrontiers in Pharmacology
Echinocandins, a prominent class of antifungals, are known for their broad-spectrum activity and favorable safety profiles. However, their bioavailability and efficacy via oral route are suboptimal. In this study, caspofungin and micafungin, the two most
Sepideh Mehravar   +5 more
doaj   +1 more source

ISEV2026 Abstract Book

open access: yes
Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit

open access: yesAntibiotics
The neonatal intensive care unit (NICU) population, especially low birth weight and critically ill neonates, is at risk of invasive Candida infections, which are associated with high mortality rates and unfavorable long-term outcomes.
Niki Dermitzaki   +5 more
doaj   +1 more source

Sunflower Oil and Cholesterol Nanoemulsion: A Novel Carrier for Micafungin to Combat Multi-Resistant Candida auris

open access: yesPathogens
Candida auris is an emerging, multidrug-resistant yeast that causes systemic infections, mainly in hospitalized or immunosuppressed patients. This pathogen has a high mortality and morbidity rate.
Gabriel Davi Marena   +12 more
doaj   +1 more source

Micafungin Sequestration and Late Release During Continuous Renal Replacement Therapy with Polyacrylonitrile- and Polysulfone-Derived Filters. [PDF]

open access: yesInfect Dis Ther
Massol J   +7 more
europepmc   +1 more source

Repurposing caspofungin as a small-molecule inhibitor of Clostridium perfringens α-toxin for treatment of gas gangrene. [PDF]

open access: yesCommun Med (Lond)
Takehara M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy